Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

Open access

Abstract

Dyslipidemia is an independent risk factor for type 2 diabetes, although exactly which of the many plasma lipids contribute to this remains unclear. We therefore investigated whether lipid profiling can inform diabetes prediction by performing liquid chromatography/mass spectrometry-based lipid profiling in 189 individuals who developed type 2 diabetes and 189 matched disease-free individuals, with over 12 years of follow up in the Framingham Heart Study. We found that lipids of lower carbon number and double bond content were associated with an increased risk of diabetes, whereas lipids of higher carbon number and double bond content were associated with decreased risk. This pattern was strongest for triacylglycerols (TAGs) and persisted after multivariable adjustment for age, sex, BMI, fasting glucose, fasting insulin, total triglycerides, and HDL cholesterol. A combination of 2 TAGs further improved diabetes prediction. To explore potential mechanisms that modulate the distribution of plasma lipids, we performed lipid profiling during oral glucose tolerance testing, pharmacologic interventions, and acute exercise testing. Levels of TAGs associated with increased risk for diabetes decreased in response to insulin action and were elevated in the setting of insulin resistance. Conversely, levels of TAGs associated with decreased diabetes risk rose in response to insulin and were poorly correlated with insulin resistance. These studies identify a relationship between lipid acyl chain content and diabetes risk and demonstrate how lipid profiling could aid in clinical risk assessment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci44442

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 1

  1. German, 2007, Curr Opin Lipidol., 18, 66

Cited by

See all 658

Metadata

Authors
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., Carr, S. A., Vasan, R. S., Florez, J. C., Clish, C. B., Wang, T. J., & Gerszten, R. E.
Affiliations
  • Broad Institute (US)
  • Boston University (US)
  • Massachusetts General Hospital (US)
Venue
Journal of Clinical Investigation
Published
2011-04-01
Volume
121
Issue
4
Pages
1402-1411
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2169156123
Cited by
647
References
33
Citations by year
2026: 17 · 2025: 31 · 2024: 48 · 2023: 54 · 2022: 65 · 2021: 57 · 2020: 52 · 2019: 47 · 2018: 38 · 2017: 41 · 2016: 44 · 2015: 33 · 2014: 40 · 2013: 45 · 2012: 25
FWCI
31.43
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Doris Duke Charitable Foundation (N01-HC-25195)
  • Donald W. Reynolds Foundation
  • American Heart Association (N01-HC-25195)
  • Endocrine Fellows Foundation
  • Fondation Leducq
  • National Institutes of Health (n01hc025195-11-0-0, N01-HC 25195)
  • National Heart, Lung, and Blood Institute (N01‐HC25195, R01HL081572, N01-HC-025195, K23HL091106)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088214, T32-DK-00754023, T32DK007540, R01-DK-HL-081572, R01DK081572)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
type 2 diabetes, insulin resistance, triglycerides, lipidomics, plasma lipids, acyl chain length, double bond content, dyslipidemia, diabetes risk prediction, oral glucose tolerance test, insulin action, acute exercise
MeSH terms
Adult, Aged, Diabetes Mellitus, Type 2, Exercise Test, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Lipids, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Molecular Structure, Biomarkers, Case-Control Studies, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. https://app.cochat.ai/papers/10.1172/jci44442
The paper
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., Carr, S. A., Vasan, R. S., Florez, J. C., Clish, C. B., Wang, T. J., & Gerszten, R. E. (2011). Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. Journal of Clinical Investigation. https://doi.org/10.1172/jci44442

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.